Redefining Role of Business Analyst in the paradigm of Big...
Transcript of Redefining Role of Business Analyst in the paradigm of Big...
© 2014 BA Convention
Redefining Role of Business Analyst in the paradigm of Big
Data in Healthcare
- Somnath Mukherjee,
General Manager, HCL Technologies Ltd.
© 2014 BA Convention 2
Click to edit Master text styles
Click to edit header
Agenda
A Day in the Life of a BA
Big Data
Pain Point
Frontier for Innovation
Characteristics
Social Intelligence
Case Study
VSDA
Big Data & Business Analyst
© 2014 BA Convention 3
Click to edit Master text styles
Click to edit header
A Day in the life of a Business Analyst
Susan, a BA is working with a global team to capture mandate and requirement of a
discovery research lab
Attending a conference
in Florida, she uses her
iPad from her hotel
room.
Hotel / Off-site
Location
She searches the Journal of
Clinical Oncology and finds an
article on predicting overall
survival of treated patients.
After reading she attends few
meetings to discuss business
requirement
Susan’s technical colleagues
review the requirement and get
into meeting with Susan for
clarification
Susan then documents the mandates
and requirements for future
reference.
Susan’s searched various literatures over
internet and studied analyst report to
understand common pain areas and major
information business is looking for
Susan then discuss with user to
get their specific business need
© 2014 BA Convention 4
Click to edit Master text styles
Click to edit header
Business Pain Points
Increasing demands on
the pharmaceutical
industry
Portfolio
innovation
New emerging
global markets
Personalized
medicine
Continued
profitability
Increased pressure
of proving “real-
world effectiveness
Product Recalls
Greater Scrutiny by FDA
Lack of efficacy
Need for personalized
medicine that has
yielded Low
Productivity in R&D
Investments
Pressure from payer
systems with less
willingness to reimburse
for line extensions and
faster introduction of
generics
Address specific
business points
Challenge in developing
new drugs that meet
patient needs and deliver
demonstrable value
Fewer Blockbuster drugs
despite increasing R&D
budgets
Declining R&D Productivity
Large Pharma is
growing a lot thru
acquisition
Need for quick
redundancy removals
and integration
Improve operating
margins
Large scale investments
in BI tools
Disparate legacy systems
Business Pain Points
© 2014 BA Convention 5
Click to edit Master text styles
Click to edit header
BIG Data: Frontier for innovation, competition & productivity Key Insights
Insight #1: Exponential data growth
Insight #2: BIG data creates value in several ways and will be
the basis for competition and growth
Insight #3: Use of BIG data will matter across sectors, some are
poised for greater gains. Similar is the situation on different
geographies.
Insight #6: Emergence of new technology and techniques with
shortage on talent availability
Insight #4: Several issues need to be addressed to capture the
full potential of BIG data
Insight #5: Shift in focal points relative to traditional
BI/Analytics
Creating Transparency
Enabling Experimentation to discover & improve performance
Segmenting population to customize actions
Replacing human decision making with automated systems
Innovating new business models, products & services
Data Policies
Technology and Techniques
organizational change and talent
Access to data
Industry structure
Reference: BIG Data Report – McKinsey and Gartner
© 2014 BA Convention 6
Click to edit Master text styles
Click to edit header
Insight View on BIG Data Characteristics
3. Debottleneck
mobile
application
space
$2bn 19%
1. Degree
2. Diversity
3. Distribution
Data Diversity/Variety
Structured
Unstructured
Semi-structured
Audio/Video
Data Distribution
Multi-location
Multi-formats
Multi-files
Data volume as a defining attribute of big
data
Terabytes/ Petabytes
Records / Transactions
Tables / Files
Delivery 4. Data feed mechanism (velocity/speed)
Internet of things
Real time
Near time
© 2014 BA Convention 7
Click to edit Master text styles
Click to edit header
Enrich Big Data/ EDW Publish
Web properties Product & services offering Social content Promotions Community connections Much more
Process social content
Text mining Analytics
Data Warehouse Big Data Integration
Analyze
Sources
Web Metrics
Internal Content
External Content
Marketing
Insights Sentiment Opinions Ideas Influencers Events Trends Patterns Exceptions
Enterprise Apps
Aggregated
Syndicate
Connect Customers
People
Products Promotions
BIG Data Reflection Social Intelligence
© 2014 BA Convention 8
Click to edit Master text styles
Click to edit header
BIG Data Reflection Social Intelligence
1
2
3 4
5
1) Business: Defines Mandate & Requirement
2) DWH: Acquires & Integrate Data
3) Data Scientist: Build & refine Analytic Model
4) BI: Publishes new insight
5) Business: Consumes insight & measures effectiveness
Technical Team
Business Analyst
Business Analyst Business Analyst
Technical Team
Business Analyst
Business Analyst
Business Goal
Business User
Business User
© 2014 BA Convention 9
Click to edit Master text styles
Click to edit header
Distribution of Effort – Big Data Lifecycle
0%
5%
10%
15%
20%
25%
30%
35%
40%
45%
Business
Objective
Data
Manipulation
Data Analysis &
Modeling
Action on
Insights or
Deployment
Learning and
guiding
15% 15% 15%
7% 7%
0%
30%
5% 3% 3%
15%
45%
20%
10% 10%
Business Analyst Technical Team % of Total Effort
© 2014 BA Convention 10
Click to edit Master text styles
Click to edit header
• VSDA is a tool that analyses VAERS (Vaccine Adverse Event Reporting System) data to draw out insights on safety of various vaccines in use based on their adverse events (AE) reporting
• The platform can carry out a comparative safety analysis of various vaccines based on the reported AE incidences
• Analysis of vaccine data by this platform could be useful to the pharma companies in decision making process based on its analysis, information and insight generation
• VSDA Tool has features to analyze the data based on multiple KPIs
• The KPIs
1. Geography / State; 2. Age, sex and dose; 3. Site of administration; 4. Symptom count by vaccine and by manufacturer; 5. Specific AE (adverse events) / by vaccine type / vaccine brands / age of vaccination); 6. Co-administered vaccines; 7. By type of vaccine; 8. By manufacturer; 9. By vaccines; 10. Co-administered drugs; 11. Hospitalization and no. of hospital days
• Capabilities
Analysis of data and the results can be presented in a dashboard with statistical representation of data in the form of graphs / charts
Ability to export analytical charts directly into power point presentations
Wh
at is
VSD
A
Cap
abili
tie
s &
KP
Is
Vaccine Safety Data Analyzer (VSDA)
© 2014 BA Convention 11
Click to edit Master text styles
Click to edit header
Key Business Questions: 1. How many adverse events were reported due to BCG vaccine between 2006 -2011? 2. What was the geographical location of such AEs in United States? 3. How many of the adverse events lead to hospitalization and for many days?
• Between 2006 -2011, 229 cases of adverse events reported due to BCG vaccine, 18% of which were from region around the Great Lakes.
• None of the adverse events resulted in any Hospital days or hospitalization.
Vaccine
Geographical Distribution
of AEs
Hospitalization and
Hospital Days
Insights
VSDA Snapshot - Adverse Event Analysis by Geography
© 2014 BA Convention 12
Click to edit Master text styles
Click to edit header
Business Analyst – Change in Definition
The role of a Business Analyst can also be defined as a media to capture and document the
business problems and pass on the same to the technology solutions group.
Business Technology
Old Definition
Solution
Business
Analyst Technical
Lead
© 2014 BA Convention 13
Click to edit Master text styles
Click to edit header
Business Analyst – Change in Definition
The role of a Business Analyst can also be defined as a bridge between the business problems
and the technology solutions.
Business Technology
New Definition
Solution
Business
Analyst
Technical
Lead
© 2014 BA Convention 14
Click to edit Master text styles
Click to edit header
Role of a Traditional Business Analyst
Understand what
the Business
Does and how it
does it
Determine how
to improve
existing business
processes
Determine which
task/steps to
automate (Gather
Requirement)
Design the
feature of IT
System (Create
Functional
Specification)
Implement the
new features of IT
system (technical
design)
Traditional Business Analyst
Business Process Analyst
IT Business Analyst
System Analyst
Specific
Roles
Requirement Engineer (Analyst)
Business Systems Analyst
Business Analyst
Title
© 2014 BA Convention 15
Click to edit Master text styles
Click to edit header
Functions of Business Analyst in Analytics space
A Guide to the Business Analysis Body of Knowledge®
(BABOK® Guide) incorporates six Knowledge Areas
along with a set of underlying competencies, and
applies to both the enterprise and to projects. The
knowledge areas are:
Business Analysis Planning and Monitoring (BAP&M)
Elicitation (E)
Requirements Management and Communication (RM&C)
Enterprise Analysis (EA)
Requirements Analysis (RA)
Solution Assessment and Validation (SA&V)
© 2014 BA Convention 16
Click to edit Master text styles
Click to edit header
Business Analysis 3i Framework B
AP
&M
R
M&
C
E EA
R
A
SA&
V
Sources Process Social Content Analyze Enrich BIG DATA Publish Inference
Identification of KPI
Business Requirement
Planning
External Content Web Metrics Pharmacy Lab Internal Content
Enterprise Apps Marketing
Data Model Data Mining What/if Analysis
Simulation
Decision Analysis
Requirement Capture
Brainstorming Data Model Interview Interface
Identification Observation
Retrospective Process Model Metrics & Reporting
User Profiling
Change Control System
Configuration Management
Coverage Metrics
Issue & Defect Reporting
Structured Walkthrough
Cost/Benefit Analysis
Prediction
Data Model Business Rule GAP Analysis Decomposition Interface Analysis
Process Model
Structured Walkthrough
Traceability Matrix
Decision Analysis
Retrospective Analysis
Co
llabo
ration
Information Interaction Intelligence
Reference: BABok 2.0 Framework
© 2014 BA Convention
Learn more. www.baconvention.com
Thank You!
For more information please reach out to Somnath Mukherjee
© 2014 BA Convention 18
Click to edit Master text styles
Click to edit header
Key Business Questions: 1. What are the major symptoms reported in analysis of adverse events due to vaccines from 2006 -2012? 2. Which vaccines gave the highest % of “injection site erythema” as adverse event? 3. Which manufacturer’s vaccine was responsible for highest incidence of injection site erythema?
• Between 2006 -2011, 18.2% of Injection site erythema were caused due to FLU vaccines. • 47.2% of the FLU vaccines that caused injection site erythema were manufactured by Company B
Major AE of Interest
VACCINE
Manufacturer
Insights
VSDA Snapshot - Adverse Event Analysis by Vaccine
© 2014 BA Convention 19
Click to edit Master text styles
Click to edit header
Key Business Questions: 1. What were the number of AE reported per manufacture from 2006 -2011? 2. Which “Flu” manufacturer had the highest % of adverse events between 2006 – 2011? 3. Which “Flu” manufacturer’s vaccine was responsible for least incidence of adverse events?
• Between 2006 -2011, 71.6% of total reported AE were due to vaccines manufacturer by Company A , B and C. • Approx. 39% of AE reported for Company A were for HPV, whereas Flu vaccines accounted for ~49% of reported AEs for Company B.
Manufacturer
VACCINE
AE Count
Insights
VSDA Snapshot - Adverse Event Analysis by Manufacturer